Global Hirudin Market Size Will Escalate to USD 4,371 Million in 2026

Global Hirudin Market Size Will Escalate to USD 4,371 Million in 2026

Hirudin is a naturally occurring peptide in the salivary glands of blood-sucking leeches that has a blood anticoagulant property. This is fundamental for the leeches’ alimentary habit of hematophagy, since it keeps the blood flowing after the initial phlebotomy performed by the worm on the host’s skin.

Market Insights

The study projects that the Hirudin market will register a 2.67% CAGR in terms of revenue, which is expected to reach USD 4,371 million in 2026 from USD 3,635 million in 2019.

Regionally, North America was the major revenue generating region in 2018 with a share of 34.52% and is expected to garner growth in the coming years. It was followed by Europe and Asia-Pacific, with a share of 32.08% and 27.63% respectively. North America is projected to dominate the market throughout the period 2019-2026.

According to the statistics, the demand cannot satisfy the supply. Currently, the hirudin market has certain potential in the US, European and Asian markets. Demand in these areas is growing rapidly.

In recent years, as a main component of hirudin in China, there are a variety of proprietary Chinese medicines, such as cerebral blood oral liquid, tablets thrombosis, blood capsule, with its annual output value of tens of millions. Continuous research and introduction of new drugs with leeches. Genetic engineering of recombinant leech-like peptide drugs to replace or hirudin as anticoagulant drug additives stasis, which can be achieved in the near future.  Further clinical studies are needed as an injection for the treatment of cardiovascular diseases and anticancer drugs. Needless to say, the development of recombinant hirudin-like peptide drugs will bring enormous social and economic benefits.

Get FREE Sample of Hirudin Market Report at:

https://www.globalmarketmonitor.com/reports/129391-global-hirudin-market-report-2018.html#download-sample

Competitive Outlook

l   Bayer Healthcare AG

l   Boehringer Ingelheim

l   Abbott India Limited

l   Sanofi S.A.

l   GlaxoSmithKline Plc.

l   Pfizer, Inc.

l   Bristol-Myers Squibb Company

l   Eisai Inc.

l   Aspen Holdings

l   Teva Pharmaceutical Industries Ltd.

l   Mitsubishi Tanabe Pharma Corporation

Type Outlook

      Natural Hirudin

      Recombinant Hirudin

Application Outlook

      Myocardial infarction

      Cerebral thrombosis

      Stroke

      Skin hematomas

      Varicose veins

      Application cream

Regions Covered in the Report:

North America (United States, Canada, and Mexico)

Europe (Germany, UK, France, Italy, Denmark, Finland, Iceland, Norway and Sweden, Spain, Belgium, Poland, Russia, Turkey, and Others)

Asia-Pacific (China, Japan, India, South Korea, Australia, New Zealand, Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, and Others)

Latin America (Brazil, Argentina, Peru, Chile, and Others)

Middle East & Africa (GCC Countries, Southern Africa, and North Africa)

Purchase a copy of Hirudin report at:

https://www.globalmarketmonitor.com/reports/129391-global-hirudin-market-report-2018.html#download-sample

The research report provides in-depth analysis on:

      The estimation of the growth rate, market size and share of the Hirudin Market throughout the forecast period.

      The assessments for the regional market layout characteristics in the world.

      The SWOT of the Hirudin Market.

      Leading manufacturers’ profiles, product features, business features, target customer features.

      Significant trends for the growth prospects of the Hirudin Market by 2026.

      The report tracks detailed information about merges, innovations, policies and recent developments in the industry.

Table of Content

1 Report Overview

1.1  Product Definition and Scope

1.2  PEST (Political, Economic, Social and Technological) Analysis of Hirudin Market

2 Market Trends and Competitive Landscape

3 Segmentation of Hirudin Market by Types

4 Segmentation of Hirudin Market by End-Users

5 Market Analysis by Major Regions

6 Product Commodity of Hirudin Market in Major Countries

7 North America Hirudin Landscape Analysis

8 Europe Hirudin Landscape Analysis

9 Asia Pacific Hirudin Landscape Analysis

10 Latin America, Middle East & Africa Hirudin Landscape Analysis  

11 Major Players Profile

11.1 Bayer Healthcare AG

11.1.1 Bayer Healthcare AG Company Profile and Recent Development

11.1.2 Market Performance

11.1.3 Product and Service Introduction

11.2 Boehringer Ingelheim

11.3 Abbott India Limited

11.4 Sanofi S.A.

11.5 GlaxoSmithKline Plc.

11.6 Pfizer, Inc.

11.7 Bristol-Myers Squibb Company

11.8 Eisai Inc.

11.9 Aspen Holdings

11.10 Teva Pharmaceutical Industries Ltd.

11.11 Mitsubishi Tanabe Pharma Corporation

Target Audience:

Hirudin end-user sectors

Hirudin industry associations

Product managers, Hirudin industry administrator, C-level executives of the industries

Healthcare organizations

Research & Clinical Laboratories

Market research and consulting firms

Small and Medium-sized Enterprises (SMEs)

Ÿ   Base Year: 2018

Ÿ   Estimated Year: 2019

Ÿ   Forecast Period: 2019 to 2026

Ask for a discount at:

https://www.globalmarketmonitor.com/reports/129391-global-hirudin-market-report-2018.html#download-sample

About US

Global Market Monitor is a company that provides comprehensive services and products to global clients. We regularly update new reports on the website, ensuring that our clients stay abreast of the latest trends in their industries.

We engage in a wide, diverse range of international businesses and have established a sound customer base with about 11,000 clients in over 102 countries and regions. Headquartered in the USA and with 6 global offices around the world, it is convenient for Global Market Monitor to get a global view for global clients.

We are always committed to deliver customized market research solutions with the highest quality. As an information service company, we are specialized in offering market intelligence services from more than 500 research institute, involving plenty of industries, companies, trends, market drivers and other strategic data. About 100 million statistics with tables, figures and datasets are easy to access. Reports provided by Global Market Monitor can reveal the interrelationship between industries and markets, so that our clients have a better understanding of the global economy, risk, opportunity and financial impact.

Contact:

Global Market Monitor

One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,

NY 11201, USA

Phone: + 1 (347) 467 7721

Email: info@globalmarketmonitor.com

Web Site: https://www.globalmarketmonitor.com

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.